← Leaderboards
Abhichart Krissanaprasit
Helixomer, Inc.
$2,042,027
Attributed
$2,042,027
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.1M · FY2023–24$2M$1.5M$1M$500K$0
'23
'24
Funding mix
By agency
NIH$2,042,027 · 1
By mechanism
R44$2,042,027 · 1
Top collaborators
No co-investigators on record.
Others in their field
Other Rising Stars on “Affect”
- Daniel Hunter Reirden · Westat, Inc.$15,038,020
- Thomas K Karikari · Wake Forest University Health Sciences$14,340,584
- Xuping Xie · University Of Texas Med Br Galveston$13,737,799
- Brian Todd Schaneberg · Illinois Institute Of Technology$13,469,813
- Benjamin M Greenberg · Ut Southwestern Medical Center$11,474,975
- Eric Anderson · Columbia University Health Sciences$11,474,975
Research focus
AffectAffinityAmericanAnalytical MethodAnaphylaxisAnimal ModelAnticoagulantsAnticoagulationAntidotesAppearanceAptamerAssay DevelopmentBase PairingBindingBiodistributionBiologicalBloodBlood Coagulation FactorCanis FamiliarisCardiac Surgery ProceduresCardiovascular SystemCessation Of LifeClinical PracticeAcute
Grant awards (2)
Development of an RNA-based anticoagulant and antidote for precise on/off coagulation control during cardiovascular procedures$1,058,454
R44 · FY2024 · HL · contact PI
Development of an RNA-based anticoagulant and antidote for precise on/off coagulation control during cardiovascular procedures$983,573
R44 · FY2023 · HL · contact PI